project id: TCGA-PRAD; case submitter id: TCGA-KC-A4BL; source center: 23; state: released; a260 a280 ratio: 1.86; age at index: 65; days to birth: -24081; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1941; age at diagnosis: 24081; ajcc clinical m: M0; ajcc clinical t: T1c; ajcc pathologic n: N0; ajcc pathologic t: T2c; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 934.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 3; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 30.0; days to collection: 2101; initial weight: 160.0; sample id: 97b5133f-9d89-4e25-9c78-655c23655dbd; sample submitter id: TCGA-KC-A4BL-01A; portion id: a7feb788-b8d1-40dd-b6cc-9639942d8481; portion submitter id: TCGA-KC-A4BL-01A-31; slide id: b268270d-8a0d-4afa-a380-15d0185f29d1; slide submitter id: TCGA-KC-A4BL-01A-03-TSC; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 40.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0; section location: TOP;